Contraindications, Warnings, and Precautions: Black Box Warning _________________ ____________________ Drug Abuse and Dependence: Risk for Dependence _________________ ____________________ Adverse Reactions: 10+ Adverse Reactions listed _________________ ____________________ Indications and Usage: Seizure, Epilepsy _________________ ____________________ Patient Counseling Information: Advises use of contraception _________________ ____________________ Drug Interactions: CYP2C9 substrate _________________ ____________________ Dosage and Administration: Dose adjustment required for renal impairment _________________ ____________________ Indications and Usage: Hypertension _________________ ____________________ Dosage Form and Strengths: Topical _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of C. difficile infection _________________ ____________________ Adverse Reactions: May cause headache _________________ ____________________ Dosage Form and Strengths: Orally Disintegrating Tablet _________________ ____________________ How Supplied/Storage and Handling: Store at room temperature _________________ ____________________ Indications and Usage: Anticoagulant _________________ ____________________ Drug Interactions: CYP3A4 substrate _________________ ____________________ Dosage and Administration: Twice- daily dosing _________________ ____________________ How Supplied/Storage and Handling: Protect from light _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of QT prolongation _________________ ____________________ Patient Counseling Information: Advises against driving or operating heavy machinery _________________ ____________________ Drug Interactions: CYP3A4 inhibitor _________________ ____________________ Drug Interactions: CYP2C9 inhibitor _________________ ____________________ Dosage Form and Strengths: Extended- release formulation _________________ ____________________ Indications and Usage: ADHD _________________ ____________________ Use in Specific Populations: Not recommended during pregnancy _________________ ____________________ Drug Interactions: Interaction with amiodarone _________________ ____________________ Indications and Usage: Antiviral _________________ ____________________ Drug Abuse and Dependence: Schedule II Controlled Substance _________________ ____________________ Dosage Form and Strengths: Transdermal patch _________________ ____________________ Indications and Usage: Combination Therapy _________________ ____________________ Adverse Reactions: May cause weight loss _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of serotonin syndrome _________________ ____________________ Indications and Usage: Diabetes _________________ ____________________ Patient Counseling Information: Advises avoiding alcohol consumption _________________ ____________________ Patient Counseling Information: Advises limiting sun exposure _________________ ____________________ Dosage Form and Strengths: Delayed- release formulation _________________ ____________________ Drug Abuse and Dependence: Schedule IV Controlled Substance _________________ ____________________ Indications and Usage: Immunization _________________ ____________________ Use in Specific Populations: Geriatric use described _________________ ____________________ Drug Interactions: CYP2D6 substrate _________________ ____________________ Dosage and Administration: Once- daily dosing _________________ ____________________ Indications and Usage: Pain _________________ ____________________ Dosage and Administration: Weekly dosing _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of hepatotoxicity _________________ ____________________ Indications and Usage: Depression _________________ ____________________ Dosage Form and Strengths: “Sprinkle” _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of nephrotoxicity _________________ ____________________ Drug Interactions: CYP3A4 inducer _________________ ____________________ Use in Specific Populations: Hepatic impairment use described _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of respiratory depression _________________ ____________________ Indications and Usage: has 3+ FDA-approved indications _________________ ____________________ How Supplied/Storage and Handling: Refrigeration required _________________ ____________________ Indications and Usage: Antibiotic _________________ ____________________ Use in Specific Populations: Has reproductive toxicity/teratogenicity warning _________________ ____________________ Use in Specific Populations: Pediatric use described _________________ ____________________ Use in Specific Populations: Renal impairment use described _________________ ____________________ Patient Counseling Information: Contains missed dose instructions _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of severe rash _________________ ____________________ Dosage Form and Strengths: Oral solution _________________ ____________________ Dosage Form and Strengths: Oral capsule _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of bleeding _________________ ____________________ Dosage Form and Strengths: Oral suspension _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of hypoglycemia _________________ ____________________ Adverse Reactions: May cause weight gain _________________ ____________________ Patient Counseling Information: Advises separation from multivitamins _________________ ____________________ Adverse Reactions: May cause nausea _________________ ____________________ Dosage Form and Strengths: Injection _________________ ____________________ Drug Interactions: CYP2D6 inhibitor _________________ ____________________ Patient Counseling Information: Must take with food _________________ ____________________ Drug Interactions: Interaction with grapefruit _________________ ____________________ Adverse Reactions: May cause drowsiness/sedation _________________ ____________________ Drug Interactions: Interaction with warfarin _________________ ____________________ Dosage and Administration: Dose adjustment required for hepatic impairment _________________ ____________________ Use in Specific Populations: Not recommended during lactation _________________ ____________________ Dosage Form and Strengths: Oral tablet _________________ ____________________ Contraindications, Warnings, and Precautions: Black Box Warning _________________ ____________________ Drug Abuse and Dependence: Risk for Dependence _________________ ____________________ Adverse Reactions: 10+ Adverse Reactions listed _________________ ____________________ Indications and Usage: Seizure, Epilepsy _________________ ____________________ Patient Counseling Information: Advises use of contraception _________________ ____________________ Drug Interactions: CYP2C9 substrate _________________ ____________________ Dosage and Administration: Dose adjustment required for renal impairment _________________ ____________________ Indications and Usage: Hypertension _________________ ____________________ Dosage Form and Strengths: Topical _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of C. difficile infection _________________ ____________________ Adverse Reactions: May cause headache _________________ ____________________ Dosage Form and Strengths: Orally Disintegrating Tablet _________________ ____________________ How Supplied/Storage and Handling: Store at room temperature _________________ ____________________ Indications and Usage: Anticoagulant _________________ ____________________ Drug Interactions: CYP3A4 substrate _________________ ____________________ Dosage and Administration: Twice- daily dosing _________________ ____________________ How Supplied/Storage and Handling: Protect from light _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of QT prolongation _________________ ____________________ Patient Counseling Information: Advises against driving or operating heavy machinery _________________ ____________________ Drug Interactions: CYP3A4 inhibitor _________________ ____________________ Drug Interactions: CYP2C9 inhibitor _________________ ____________________ Dosage Form and Strengths: Extended- release formulation _________________ ____________________ Indications and Usage: ADHD _________________ ____________________ Use in Specific Populations: Not recommended during pregnancy _________________ ____________________ Drug Interactions: Interaction with amiodarone _________________ ____________________ Indications and Usage: Antiviral _________________ ____________________ Drug Abuse and Dependence: Schedule II Controlled Substance _________________ ____________________ Dosage Form and Strengths: Transdermal patch _________________ ____________________ Indications and Usage: Combination Therapy _________________ ____________________ Adverse Reactions: May cause weight loss _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of serotonin syndrome _________________ ____________________ Indications and Usage: Diabetes _________________ ____________________ Patient Counseling Information: Advises avoiding alcohol consumption _________________ ____________________ Patient Counseling Information: Advises limiting sun exposure _________________ ____________________ Dosage Form and Strengths: Delayed- release formulation _________________ ____________________ Drug Abuse and Dependence: Schedule IV Controlled Substance _________________ ____________________ Indications and Usage: Immunization _________________ ____________________ Use in Specific Populations: Geriatric use described _________________ ____________________ Drug Interactions: CYP2D6 substrate _________________ ____________________ Dosage and Administration: Once- daily dosing _________________ ____________________ Indications and Usage: Pain _________________ ____________________ Dosage and Administration: Weekly dosing _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of hepatotoxicity _________________ ____________________ Indications and Usage: Depression _________________ ____________________ Dosage Form and Strengths: “Sprinkle” _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of nephrotoxicity _________________ ____________________ Drug Interactions: CYP3A4 inducer _________________ ____________________ Use in Specific Populations: Hepatic impairment use described _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of respiratory depression _________________ ____________________ Indications and Usage: has 3+ FDA-approved indications _________________ ____________________ How Supplied/Storage and Handling: Refrigeration required _________________ ____________________ Indications and Usage: Antibiotic _________________ ____________________ Use in Specific Populations: Has reproductive toxicity/teratogenicity warning _________________ ____________________ Use in Specific Populations: Pediatric use described _________________ ____________________ Use in Specific Populations: Renal impairment use described _________________ ____________________ Patient Counseling Information: Contains missed dose instructions _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of severe rash _________________ ____________________ Dosage Form and Strengths: Oral solution _________________ ____________________ Dosage Form and Strengths: Oral capsule _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of bleeding _________________ ____________________ Dosage Form and Strengths: Oral suspension _________________ ____________________ Contraindications, Warnings, and Precautions: Risk of hypoglycemia _________________ ____________________ Adverse Reactions: May cause weight gain _________________ ____________________ Patient Counseling Information: Advises separation from multivitamins _________________ ____________________ Adverse Reactions: May cause nausea _________________ ____________________ Dosage Form and Strengths: Injection _________________ ____________________ Drug Interactions: CYP2D6 inhibitor _________________ ____________________ Patient Counseling Information: Must take with food _________________ ____________________ Drug Interactions: Interaction with grapefruit _________________ ____________________ Adverse Reactions: May cause drowsiness/sedation _________________ ____________________ Drug Interactions: Interaction with warfarin _________________ ____________________ Dosage and Administration: Dose adjustment required for hepatic impairment _________________ ____________________ Use in Specific Populations: Not recommended during lactation _________________ ____________________ Dosage Form and Strengths: Oral tablet _________________ ____________________
(Print)
Contraindications, Warnings, and Precautions: Black Box Warning _________________ ____________________
Drug Abuse and Dependence: Risk for Dependence _________________ ____________________
Adverse Reactions: 10+ Adverse Reactions listed _________________ ____________________
Indications and Usage: Seizure, Epilepsy _________________ ____________________
Patient Counseling Information: Advises use of contraception _________________ ____________________
Drug Interactions: CYP2C9 substrate _________________ ____________________
Dosage and Administration: Dose adjustment required for renal impairment _________________ ____________________
Indications and Usage: Hypertension _________________ ____________________
Dosage Form and Strengths: Topical _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of C. difficile infection _________________ ____________________
Adverse Reactions: May cause headache _________________ ____________________
Dosage Form and Strengths: Orally Disintegrating Tablet _________________ ____________________
How Supplied/Storage and Handling: Store at room temperature _________________ ____________________
Indications and Usage: Anticoagulant _________________ ____________________
Drug Interactions: CYP3A4 substrate _________________ ____________________
Dosage and Administration: Twice-daily dosing _________________ ____________________
How Supplied/Storage and Handling: Protect from light _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of QT prolongation _________________ ____________________
Patient Counseling Information: Advises against driving or operating heavy machinery _________________ ____________________
Drug Interactions: CYP3A4 inhibitor _________________ ____________________
Drug Interactions: CYP2C9 inhibitor _________________ ____________________
Dosage Form and Strengths: Extended-release formulation _________________ ____________________
Indications and Usage: ADHD _________________ ____________________
Use in Specific Populations: Not recommended during pregnancy _________________ ____________________
Drug Interactions: Interaction with amiodarone _________________ ____________________
Indications and Usage: Antiviral _________________ ____________________
Drug Abuse and Dependence: Schedule II Controlled Substance _________________ ____________________
Dosage Form and Strengths: Transdermal patch _________________ ____________________
Indications and Usage: Combination Therapy _________________ ____________________
Adverse Reactions: May cause weight loss _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of serotonin syndrome _________________ ____________________
Indications and Usage: Diabetes _________________ ____________________
Patient Counseling Information: Advises avoiding alcohol consumption _________________ ____________________
Patient Counseling Information: Advises limiting sun exposure _________________ ____________________
Dosage Form and Strengths: Delayed-release formulation _________________ ____________________
Drug Abuse and Dependence: Schedule IV Controlled Substance _________________ ____________________
Indications and Usage: Immunization _________________ ____________________
Use in Specific Populations: Geriatric use described _________________ ____________________
Drug Interactions: CYP2D6 substrate _________________ ____________________
Dosage and Administration: Once-daily dosing _________________ ____________________
Indications and Usage: Pain _________________ ____________________
Dosage and Administration: Weekly dosing _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of hepatotoxicity _________________ ____________________
Indications and Usage: Depression _________________ ____________________
Dosage Form and Strengths: “Sprinkle” _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of nephrotoxicity _________________ ____________________
Drug Interactions: CYP3A4 inducer _________________ ____________________
Use in Specific Populations: Hepatic impairment use described _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of respiratory depression _________________ ____________________
Indications and Usage: has 3+ FDA-approved indications _________________ ____________________
How Supplied/Storage and Handling: Refrigeration required _________________ ____________________
Indications and Usage: Antibiotic _________________ ____________________
Use in Specific Populations: Has reproductive toxicity/teratogenicity warning _________________ ____________________
Use in Specific Populations: Pediatric use described _________________ ____________________
Use in Specific Populations: Renal impairment use described _________________ ____________________
Patient Counseling Information: Contains missed dose instructions _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of severe rash _________________ ____________________
Dosage Form and Strengths: Oral solution _________________ ____________________
Dosage Form and Strengths: Oral capsule _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of bleeding _________________ ____________________
Dosage Form and Strengths: Oral suspension _________________ ____________________
Contraindications, Warnings, and Precautions: Risk of hypoglycemia _________________ ____________________
Adverse Reactions: May cause weight gain _________________ ____________________
Patient Counseling Information: Advises separation from multivitamins _________________ ____________________
Adverse Reactions: May cause nausea _________________ ____________________
Dosage Form and Strengths: Injection _________________ ____________________
Drug Interactions: CYP2D6 inhibitor _________________ ____________________
Patient Counseling Information: Must take with food _________________ ____________________
Drug Interactions: Interaction with grapefruit _________________ ____________________
Adverse Reactions: May cause drowsiness/sedation _________________ ____________________
Drug Interactions: Interaction with warfarin _________________ ____________________
Dosage and Administration: Dose adjustment required for hepatic impairment _________________ ____________________
Use in Specific Populations: Not recommended during lactation _________________ ____________________
Dosage Form and Strengths: Oral tablet _________________ ____________________
